The panel shares perspectives on how climate change will impact community immunity and access to care. Panelists offer their perspective on the use of telehealth in the care of individuals with HIV. Panelists discuss the burden of mental health and substance use disorders on individuals living with HIV. HIV physicians reflect on how delivering accurate and timely information and treatment for patients newly diagnosed with HIV. HIV physicians discuss building trust with their patients to alleviate the burden of stigma in the health care setting. Panelists discuss how health care policy, education, and insurance coverage impact access to HIV prevention. Panelists discuss HIV prevention options and new drug developments that could improve prevention. Limited access to healthcare, driven by factors like employment discrimination, suggests a link to increased risk behaviors. In people Living with chronic HIV, viral damage to the gut may lead to increased intestinal permeability (leaky gut). People with HIV and intellectual and developmental disabilities are less likely to receive an HIV diagnosis. A hospital-wide intervention showed improvement in HIV PrEP delivery in Black and Hispanic women. Demographic factors may impact which HIV-positive women receive LAI versus oral ART. Peer navigation and a mobile app might be the solution to closing the gap in care for Hispanic and Black people with HIV. Patients with HIV and cancer have worse outcomes due to disparities in treatment. Vatsana Chanthala and MarkAlain Déry, DO, MPH, FACOI, discuss programs in New Orleans that address disparities in HIV care. Disparities in HIV diagnoses among Black and White populations have decreased since 2017. MarkAlain Déry, DO, MPH, FACOI, interviews Vatsana Chanthala about disparities in HIV care. Nearly 2 in 10 people living with HIV who initiated antiretroviral therapy were lost to follow-up. Researchers created the HBCU-HIV Prevention Project to determine its usefulness in reducing risk of HIV. Two years of pitavastatin use can help lower noncalcified plaque volume and inflammatory biomarkers in people living with HIV